EXPE declined roughly 21.5% over the past 30 days, from a close near $333.44 on August 26 to about $261.75 by September 24. The selloff was driven primarily by the launch of Meta's AI assistant "Muse," which raised fears that agentic AI could bypass online travel agencies and compress take rates.

QCML gained roughly +44% over the last 30 days, rising from about $14.23 to approximately $20.51, as its underlying exposure to Qualcomm surged. The fund seeks 2x (200%) the daily return of Qualcomm common stock, amplifying both gains and losses on a single-session basis.

TZA climbed roughly 21% over the trailing 30 days as the small-cap Russell 2000 Index declined. The fund seeks 300% of the inverse (-3x) of the Russell 2000's daily return, amplifying short-term small-cap weakness.

SRTY is a leveraged inverse exchange-traded fund (ETF) designed to deliver three times the inverse (-3x) of the Russell 2000 Index's daily performance. The fund gained approximately +17.6% over the last 30 days as small-cap equities pulled back.

LOFF climbed roughly 12% over the last 30 days, rising from approximately $14.54 to a latest close near $16.33. The fund is a 2x daily-leveraged exchange-traded fund (ETF) tied to SpaceX shares, so its move reflects roughly twice the underlying stock's daily performance.

HYPG advanced roughly 15% over the trailing 30 days as HYPE, its sole underlying asset, climbed to record highs. Over the trailing quarter, the fund rose approximately 56% , reflecting a sustained rally in Hyperliquid's native token.

COST shares declined roughly 6.2% over the trailing 30 days, easing from about $956 to around $896 per share. The pullback is modest in magnitude, keeping the move well below the 10% threshold and signaling consolidation rather than a sharp correction.

Advanced Micro Devices shares climbed roughly 30.8% over the trailing 30 days, from a close of $480.93 on August 26 to $629.26 on September 24, 2026. The advance pushed AMD's market capitalization above $1 trillion for the first time, making it the fourth U.S. chipmaker to cross that milestone.

Marvell Technology (MRVL) rose roughly 5.7% over the trailing 30 days, from about $245.11 to $258.95, a move well below the 10% threshold that would signal a sharp directional swing. Fiscal second-quarter results set records — revenue of $2.74 billion, up 37% year over year, with adjusted EPS of $0.94 — but shares initially fell on a thin beat and lower near-term margin guidance.

GLND climbed roughly 282% over the trailing 30 days, rising from about $1.40 to $5.35. The move was driven primarily by a U.S.–Denmark–Greenland security agreement that put Greenland-linked resource stocks in the spotlight.

CTNT shares fell roughly 97.9% over the past 30 days, from a close of $1.51 on August 26, 2026, to $0.0321 on September 24, 2026. The decline was driven primarily by a sharp increase in shares outstanding through equity financings, which heavily diluted existing holders.

INLF shares fell roughly 30% over the trailing 30 days, declining from about $4.23 to $2.95, extending a sustained multi-month downtrend. The decline reflects persistent selling pressure in an ultra-low-float micro-cap that completed a 1-for-16 reverse stock split in April 2026 as part of a Nasdaq compliance initiative.

META shares climbed roughly 36% over the last 30 days, from about $570 to a closing price of $777.59, marking the stock's best month since July 2013. The rally was powered by the launch of Meta's Muse AI assistant, which surged to the top of U.S. app-store charts and renewed confidence in the company's heavy AI spending.

BlackBerry (BB) shares climbed roughly 12% over the trailing 30 days, from $7.79 to $8.73, rebounding off early-September lows. The move was driven primarily by stronger-than-expected fiscal 2027 second-quarter results, with revenue up 26% and adjusted EPS of $0.07 beating consensus estimates.

Prime Medicine (PRME) shares fell roughly 14% over the trailing 30 days, from a close of $3.58 on August 26, 2026 to $3.07 on September 24, 2026. The decline occurred despite a steady stream of pipeline milestones, underscoring ongoing volatility and selling pressure across the gene-editing sector.

Akamai shares have moved only modestly over the past 30 days, holding near $110 after a sharp mid-September rally and subsequent pullback. The defining catalyst is a seven-year, $11.6 billion cloud infrastructure agreement with Anthropic—the largest contract in Akamai's history—with expansion potential toward $20 billion.

AEM and KGC are both Canadian senior gold producers, but their recent performance and outlooks have diverged sharply despite exposure to the same gold price. AEM has posted record free cash flow and trades at a premium valuation, while KGC recently cut its production guidance and raised its cost outlook.

IONQ operates a diversified "full-stack" quantum platform spanning computing, networking, and sensing, while RGTI focuses on vertically integrated superconducting quantum computers. IonQ has delivered rapid revenue growth and became the first public quantum company to exceed $100 million in annual revenue; Rigetti's revenue base remains far smaller and more contract-dependent.

ZBIO fell -9.96% during regular trading hours to roughly $26.68, down from the prior session's close of $29.63. The primary catalyst was a newly filed shelf registration covering up to 7 million shares, stoking dilution fears among holders.

EOSE is down roughly -10.06% intraday during regular trading, sliding from a $3.58 prior close to near $3.22. Primary catalyst: a wave of securities litigation-firm investigations into potential corporate wrongdoing, keeping legal and governance risk front and center.